Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T21:41:32.035Z Has data issue: false hasContentIssue false
  • English
  • Français

Theory-Driven Interventions in Psychoneuroimmunology and HIV-1 Infection

Published online by Cambridge University Press:  07 November 2014

Mary D. Tyll ,
Karl Goodkin ,
Nancy T. Blaney ,
Teri T. Baldewicz ,
Jodi Dee Hunt  and
Deshratn Asthana
Get access Rights & Permissions [Opens in a new window]

Abstract

Psychoneuroimmunology (PNI) is a rapidly evolving multidisciplinary field founded on the premise that psychosocial factors, the central nervous system, and the immune system are intimately linked. Following publication of scientific evidence supporting this link, a number of animal and human studies have been published, both inside and outside the area of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome. These studies support the existence of bidirectional feedback mechanisms operating between the brain and the immune system. To date, however, there is no all-encompassing model that predicts individual differences in the relationship among psychosocial factors, immunologic measures, and clinical disease progression in HIV type 1 (HIV-1) infection. This variability in human response has been explained by a number of cofactors (host as well as environmental) that appear to accelerate the course of the disease.

Since psychosocial factors are highly amenable to behavioral interventions, several models for intervention research have been proposed to evaluate whether such interventions can enhance immune functioning, thereby curtailing disease progression. Examination of these interventions in the context of PNI and HIV-1 infection, however, is rather limited. Therefore, researchers and clinicians must not only consider conceptualizations and paradigms in this area of research, but also focus on empirically testable, theory-driven models that allow for the unique characteristics of individual patients.

Type
Feature Articles
Information
CNS Spectrums , Volume 5 , Issue 5: HIV and the Central Nervous System: Part Two , May 2000 , pp. 25 - 32
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Solomon, GF, Moos, RH. Emotions, immunity, and disease: A speculative theoretical integration. Arch Gen Psychiatry. 1964;11:657–674.CrossRefGoogle ScholarPubMed
2.Levy, S, Heberman, R, Lippman, M, Angelo, T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 1987;5:348–353.CrossRefGoogle ScholarPubMed
3.Goodkin, K, Appels, A. Behavioral-neuroendocrine-immunologic interactions in myocardial infarction. Med Hypotheses. 1997;48:209–214.CrossRefGoogle ScholarPubMed
4.Byrnes, DM, Antoni, MH, Goodkin, K, Efantis-Potter, J, Asthana, D, Simon, T, Munaji, J, Ironson, G, Fletcher, MA. Stressful events, pessimism, natural killer cells cytotoxicity, and cytotoxie/suppressor T cells in HIV+ black women at risk for cervical cancer. Psychosom Med. 1998;60:714–722.CrossRefGoogle Scholar
5.Visser, APh, Goodkin, K, Vingerhoets, A, Peters, AAW, Boon, M, Garssen, B, Fletcher, MA. Cervical cancer: Psychosocial and psychoneuroimmunological issues. In: Goodkin, K, Visser, APh, Eds. Psychoneuroimmunology: Stress, Mental Disorders and Health. Washington, DC: American Psychiatric Press; 2000:41–76.Google Scholar
6.Fawzy, I, Kemeny, M, Fawzy, N, Elashoff, R, Morton, D, Cousins, N, Fahey, J. A structured psychiatric intervention for cancer patients. II. Changes over time in immunologic measures. Arch Gen Psychiatry. 1990;47:729–735.CrossRefGoogle Scholar
7.Fawzy, FI, Fawzy, NW, Hyun, CS, Elashoff, R, Guthrie, D, Fahey, JL, Morton, DL. Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50:681–689.CrossRefGoogle ScholarPubMed
8.Kiecolt-Glaser, JK, Glaser, R. Methodological issues in behavioral immunology research with humans. Brain, Behav Immunol. 1988;2:67–78.CrossRefGoogle Scholar
9.Goodkin, K, Mulder, CL, Blaney, NT, Ironson, G, Kumar, M, and Fletcher, MA. Psychoneuroimmunology and HIV-1 infection revisited. Arch Gen Psychiatry. 1994;51:246–247.Google Scholar
10.Goodkin, K, Feaster, DJ, Asthana, D, et al.A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and on number of physician visits. Clin Diagn Lab Immunol. 1998;5:382–391.CrossRefGoogle ScholarPubMed
11.Gorman, JM, Kertzner, R. Psychoneuroimmunology and HIV infection. J Neuropsychiatry Clin Neurosci. 1990;2:241–252.Google ScholarPubMed
12.Goodkin, K. Psychoneuroimmunology and viral infection with a special note on AIDS. In: Balner, H, Ed. Publications of the Helen Dowling Institute for Biopsychosoical Medicine. 1. A New Medical Model A Challenge for Biomedicine? Rockville, Md: Swets & Zeitlinger, BV; 1990:53–64.Google Scholar
13.Solomon, GF, Temoshok, L. A psychoneuroimmunologic perspective on AIDS research: Questions, preliminary findings, and suggestions. J Appl Soc Psychol. 1987;17(3):286–308.CrossRefGoogle Scholar
14.Solomon, GF. Psychoneuroimmunology: Interactions between central nervous system and immune system. J Neurosci Res. 1987;18:1–9.CrossRefGoogle ScholarPubMed
15.Goodkin, K, Fuchs, I, Feaster, Det al.Life stressors and coping style are associated with immune measures in HIV-1 infection: A preliminary report. Int J Psychiatry in Med. 1992;22(2):155–172.CrossRefGoogle ScholarPubMed
16.Kiecolt-Glaser, JK, Glaser, R. Psychoneuroimmunology and health consequences: Data and shared mechanisms. Psychosom Med. 1995;57:269–274.CrossRefGoogle ScholarPubMed
17.Theorell, T, Blomkvist, V, Jonsson, H, et al.Social support and the development of immune function in human immunodeficiency virus infection. Psychosom Med. 1995;57:32–36.CrossRefGoogle ScholarPubMed
18.Goodkin, K, Blaney, NT, Feaster, D, et al.Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. J Psychosom Res. 1992;36:635–650.CrossRefGoogle ScholarPubMed
19.Perry, S, Rabkin, J. Psychoneuroimmunology and HIV-1 infection revisited. Arch Gen Psychiatry. 1994;51:247.Google Scholar
20.van den Boom, F. Methodological and theoretical reflections on PNI, HIV and coping. Patient Educ Counseling. 1996;28:85–91.CrossRefGoogle ScholarPubMed
21.Nott, KH, Vedhara, K, Spickett, GP. Psychology, immunology, and HIV. Psychoneuroendocrinol. 1995;20:451–474.CrossRefGoogle ScholarPubMed
22.Goodkin, K. A preliminary report of cross sectional studies of stress, social support, and coping style indices in HIV spectrum disorders. Abstract of papers presented at: AAAS Annual Meeting; January 1989; Washington, DC: 51–52.Google Scholar
23.Goodkin, K, Antoni, MH, Sevin, B, et al.A partially, testable model of psychosocial factors in the etiology of cervical cancer. I. A review of biological, psychological and social aspects. Psycho-Oncology. 1993;2(2):79–98.CrossRefGoogle Scholar
24.Goodkin, K, Antoni, MH, Sevin, B, et al.A partially, testable model of psychosocial factors in the etiology of cervical cancer. II. Bioimmunological, psychoneuroimmunological, and socioimmunological aspects, critique and prospective integration. Psycho-Oncology. 1993;2(2):99–121.CrossRefGoogle Scholar
25.Blaney, NT, Goodkin, K, Feaster, D, et al.A psychosocial model of distress over time in early HIV-1 infection: The role of life stressors, social support and coping. Psychol Health. 1997;12(6):633–653.CrossRefGoogle Scholar
26.Feaster, D, Goodkin, K, Blaney, NT, et al.Longitudinal psychoneuroimmunological relationships in the natural history of HIV-1 infection: A theoretical model. In: K, Goodkin and APh, Visser, Eds. Psychoneuroimmunology: Stress, Mental Disorders and Health. Washington DC: American Psychiatric Press; 2000:153–194.Google Scholar
27.Kiecolt-Glaser, JK, Fisher, LD, Ogrocki, P, et al.Marital quality, marital disruption, and immune function. Psychosom Med. 1987;49:13–34.CrossRefGoogle ScholarPubMed
28.Kiecolt-Glaser, JK, Kennedy, S, Malkoff, S, et al.Marital discord and immunity in males. Psychosom Med. 1988;50:213–229.CrossRefGoogle ScholarPubMed
29.Kiecolt-Glaser, JK, Glaser, R, Cacioppo, JT, et al.Marital stress: Immunologic, neuroendocrine, and autonomic correlates. Ann NY Acad Sci. 1998;840:656–663.CrossRefGoogle ScholarPubMed
30.Brooks, J. The sad and tragic life of typhoid Mary. CMAJ. 1996;154:915–916.Google ScholarPubMed
31.Blaney, NT, Goodkin, K, Morgan, RO, et al.A stress-moderator model of distress in early HIV infection: Concurrent analysis of life events, hardiness, and social support. J Psychosom Res. 1991;35(2/3):297–305.CrossRefGoogle ScholarPubMed
32.Kobasa, S, Maddi, S, and Kahn, S. Hardiness and health: A prospective study. J Personality Soc Psychol. 1982;42(1):168–177.CrossRefGoogle ScholarPubMed
33.Lichtenstein, B. Psychoneuroimmunology and HIV. STEP Perspect. 1995;7(2):6–9.Google ScholarPubMed
34.LaPerriere, AR, Antoni, MH, Schneiderman, N, et al.Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self-Regul. 1990;15:229–242.CrossRefGoogle ScholarPubMed
35.LaPerriere, A, Ironson, G, Antoni, MH, et al.Exercise and psychoneuroimmunology. Med Sci Sports Exerc. 1994;26(2):182–190.CrossRefGoogle ScholarPubMed
36.Antoni, MH, Baggett, L, Ironson, G, et al.Cognitive-behavior stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol. 1991;59(6):906–915.CrossRefGoogle Scholar
37.Coates, TJ, McKusick, L, Kuno, R, et al.Stress reduction training changed number of sexual partners but not immune function in men with HIV. Am J Pub Health. 1980;79:885–887.CrossRefGoogle Scholar
38.Mulder, CL, Antoni, MH, Duivenvoorden, HJ, et al.Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J Psychosom Res, 1995;39(8):957–965.CrossRefGoogle Scholar
39.Nicholas, PK, Webster, A. A behavioral medicine intervention in persons with HIV. Clin Nurs Res. 1996;5:391–406.CrossRefGoogle ScholarPubMed
40.Goodkin, K, Tuttle, RS, Blaney, NT, et al.Bereavement, immunity, and the impact of bereavement support groups in HIV-1 infection. In: Goodkin, K, Visser, AP, Eds. Psychoneuroimmunology: Stress, mental disorders, and Health. Washington, DC: American Psychiatric Press; 2000:357–394.Google Scholar
41.Targ, EF, Karasic, DH, Diefenbach, PN, et al.Structured group therapy and fluoxetine to treat depression in HIV-positive persons. Psychosom. 1994;35:132–137.CrossRefGoogle ScholarPubMed
42.Auerbach, JE, Oleson, TD, Solomon, GF. A behavioral medicine intervention as an adjunctive treatment for HIV-related illness. Psychol Health. 1992;6:325–334.CrossRefGoogle Scholar
43.Reed, MS. Hypnosis in the treatment of AIDS. In: Matthews, WJ, Edgette, JH, Eds. Current Thinking and Research in Brief Therapy: Solutions, Strategies, Narratives. Vol 1. New York, NY: Brunnel/Mazel; 1997:115–133.Google Scholar
44.Taylor, DN. Effects of a behavioral stress-management program in anxiety, mood, self-esteem, and T-cell count in HIV positive men. Psychol Rep. 1995;76:451–457.CrossRefGoogle ScholarPubMed
45.Goodkin, K, Antoni, MH, Helder, L, et al.Psychoneuroimmunological aspects of disease progression among women and human papillo-mavirus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection. Int J Psychiatry Med. 1993;23(2):119–148.CrossRefGoogle Scholar
46.Goodkin, K, Feaster, DJ, Tuttle, R, et al.Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic HIV-1 seropositive homosexual men. Clin Diagn Lab Immunol. 1996;3(1):109–118.CrossRefGoogle Scholar
47.Fleishman, JA, Fogel, B. Coping and depressive symptoms among young people with AIDS. Health Psychol. 1994;13:156–169.CrossRefGoogle Scholar
48.Folkman, S, Chesney, M, Pollack, L, et al.Stress, control, coping, and depressive mood in human immunodeficiency virus-positive and -negative gay men in San Francisco. J Nerv Ment Dis. 1993;181:409–416.CrossRefGoogle ScholarPubMed
49.Pakenham, KI, Dadds, MR, Terry, DJ. Relationships between adjustment to HIV and both social support and coping. J Consult Clin Psychol. 1994;62:1194–1203.CrossRefGoogle ScholarPubMed
50.Perry, S, Fishman, B, Jacobsberg, L, et al.Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry. 1992;49:396–401.CrossRefGoogle ScholarPubMed
51.Rabkin, JG, Williams, JBW, Remien, RH, et al.Depression, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry. 1991;48:111–119.CrossRefGoogle ScholarPubMed
52.Sahs, JA, Goetz, R, Reddy, M, et al.Psychological distress and natural killer cells in gay men with and without HIV infection. Am J Psychiatry. 1994;151:1479–1484.Google ScholarPubMed
53.Burack, JH, Barrett, DC, Stall, RD, et al.Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. J Am Med Assoc. 1993;270:2568–2573.CrossRefGoogle ScholarPubMed
54.Lyketsos, CG, Hoover, DR, Guccione, M, et al.Depressive symptoms as predictors of medical outcomes in HIV infection. J Am Med Assoc. 1993;270:2563–2567.CrossRefGoogle ScholarPubMed
55.Kemeny, ME, Weiner, H, Duran, R, et al.Immune system changes after the death of a partner in HIV-positive gay men. Psychosom Med. 1995;57:547–554.CrossRefGoogle ScholarPubMed
56.Goodkin, K, Baldewicz, T, Blaney, N, et al. A bereavement support group affects HIV-1 load. Scientific Program and Abstracts (#P 1-1:154) presented at: 18th Annual Meeting of the American Society for Virology; July 10–14, 1999; Amherst, Mass.Google Scholar
57.Ironson, G, Field, T, Scafidi, F, et al.Massage therapy is associated with enhancement of the immune system=s cytotoxic capacity. Int J Neurosci. 1996;84:205–217.CrossRefGoogle ScholarPubMed
58.Vieille, RC. The use of hypnosis, self-hypnosis, mental imagery, and naturalistic trance to enhance immunity and health in gay men with HIV: A contextualistic perspective. Dissertation Abstracts International: Section B: Sci Eng. 1998;58(10B):5692.Google Scholar
59.American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994:341.Google Scholar
60.Leibenluft, E. Gender differences in major depressive disorder and bipolar disorder. CNS Spectrums. 1999;4(10):25–33.CrossRefGoogle ScholarPubMed
61.Keller, SE, Schleifer, SJ, Bartlett, JA, et al.Stress, Depression, Immunity, and Health. In: Goodkin, K, Visser, APh, Spiegel, D, Eds. Psychoneuroimmunology: Stress, Mental Disorders, and Health, Progress in Psychiatry Series. Washington, DC: American Psychiatric Press; 2000:1–26.Google Scholar
62.Brauchli, P, Zeier, H. Depressive affect and surrogate markers in HIV infected patients. Psychotherapie, Psychosomatik, Medizinische Psychologie. 1997;47:34–40.Google ScholarPubMed
63.Lyketsos, CG, Hoover, DR, Guccione, M, et al.Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996;153:1430–1437.Google ScholarPubMed
64.Mayne, TJ, Vittinghoff, E, Chesney, MA, et al.Depressive affect and survival among gay and bisexual men infected with HIV. Arch Int Med. 1996;156:2233–2238.CrossRefGoogle ScholarPubMed
65.Goodkin, K, Blaney, NT, Tuttle, RS, et al.Bereavement and HIV infection. Int Rev Psychiatry. 1996;8:201–216.CrossRefGoogle Scholar
66.Wilkie, FL, van Zuilen, MH, Goodkin, K, et al.Effects of age and HIV-1 infection on cognitive functioning. Gerontologist. 1999;39(special issue 1):111–112.Google Scholar